KRAS and colorectal cancer: This pilot study involving 12 patients exploring intra-tumour heterogeneity of colorectal cancer has demonstrated relative homogeneity of genetic factors (BRAF and KRAS mutations), as well as epigenetic homogeneity (in terms of DNA methylation).